Post-Traumatic Stress Disorder Market Trends Stepping Up with a Competent CAGR Value

Comments · 340 Views

Post-Traumatic Stress Disorder Market Size is projected to grow to USD 1.60 billion by 2030, exhibiting a (CAGR) of 4.80% during the forecast period (2022 - 2030)

Post-Traumatic Stress Disorder Market Scope

Post-Traumatic Stress Disorder Market sharereport has valued the industry size at USD 1.1 billion in 2021 and is projected to grow from USD 1.15 Billion in 2022 to USD 1.60 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.80% during the forecast period (2022 - 2030).

Post-traumatic stress disorder or PTSD is a type of psychological condition, which has an impact on people regardless of their age or gender. Some of the key symptoms of PTSD arise almost immediately post the traumatic experience while others occur over a certain course of time. Some of the symptoms include mood swings, avoiding stressful situations, and more. The prevalence of the condition is statistically more among women. The higher rate of domestic and sexual abuse among the female population worldwide leads to the occurrence of the mental disorder.

Key Drivers and Impediments

The unusually high burden of various mental issues among people that give rise to post-traumatic stress disorder has fostered the market size to a huge extent. Significant rise in violence, cross-borders tensions, accidents and occupational hazards add value to the Post-Traumatic Stress Disorder industry. Additionally, the emergence of several rehabilitation programs, particularly for wounded military personnel can most likely elevate the growth rate of the Post-Traumatic Stress Disorder market in the coming years.

Majority of the leading firms are adopting growth strategies to up their relevance in the global market, some of which include partnerships, acquisitions, collaborations, mergers, joint venture, launch of new product ranges, product innovation, technical innovations in the manufacturing process, and others. This helps the companies bolster their customer base, especially in emerging markets.

Speaking of emerging markets, Latin America and the Middle East and Africa show a lot of promise, considering the rising healthcare spending, rising adoption rate, and the uptake of cutting-edge manufacturing technologies. The mounting number of government initiatives, and the soaring number of well-equipped treatment facilities further encourage business growth in these regions.

Market Segmentation

The post-traumatic stress disorder industry has been considered for treatment, as well as end-user.

The treatment-based segments highlighted in the review report are anti-anxiety medications, prazosin, medications, psychotherapy, and others.

Major end-users listed are ambulatory surgical centers, clinics, hospitals, home care, senior citizen centers, and more.

Regional Outlook

North America has bagged the leading spot in the worldwide market for Post-Traumatic Stress Disorder, given the drastic increase in the number of mental disorders arising from sexual molestation, childhood physical abuse, physical attack, combat exposure, rape, and childhood neglect.

Europes growing prominence in the global market is notable, with the region capturing the second place. The market size in the region has been blossoming on the back of the surge in human right issues such as sexual violence leaving long as well as a short-term impact on the mental health. The significant focus on research and development activities among major companies in the region further bolsters the market value.

As the fastest-progressing market, Asia Pacific benefits from the fast-emerging countries with booming population. China and India stand at the vanguard of the APAC market, thanks to the alarming rise in road accidents coupled with the surge in various traumatic events and more.

Major Companies

Mylan NV (US), Bionomics (Australia), GlaxoSmithKline (UK), Azevan Pharmaceuticals (US), Eli Lilly and Company (US), Tonix Pharmaceuticals Holding Corp. (US), Pfizer (US), Greenstone LLC (US), H. Lundbeck A/S (Denmark), Marinus Pharmaceuticals, Inc. (US) are the biggest plaayers profiled in thepost-traumatic stress disorder market trendsreport.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com

Comments

DealMirror is a SAAS Marketplace.